Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction

American Heart Journal

Volumn 138, Issue 5 I, 1999, Pages 908-915

  Ueda, K ^a   Takahashi, M ^a   Ozawa, K ^a   Kinoshita, M ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CYTOKINE PRODUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART MUSCLE INJURY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0032692861     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70016-5     Document Type: Article

References (44)

1. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997;95:778-811.
2. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996;2:243-9.
3. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
4. Heinrich PC, Castell J, Andus T. Interleukin-6 and the acute-phase response. Biochem J 1990;265:621-36.
5. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, et al. Serum interleukin-6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24:579-84.
6. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RRW, Sanders GTB. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 1992;119:574-9.
7. Miyao Y, Yasue H, Ogawa H, Misumi T, Masuda T, Sakamoto T, et al. Elevated plasma intefieukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993;126:1299-304.
8. Tashiro H, Shimokawa H, Yamamoto K, Nagao M, Momohara M, Muramatu K, et al. Monocyte-related cytokines in acute myocardial infarction. Am Heart J 1995;130:446-52.
9. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-55.
10. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-62.
11. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-86.
12. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992;148:2175-80.
13. Mackiewicz SH, Heinrich PC, Rose-John S. Complex of soluble human IL-6 receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 1992;149:2021-7.
14. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150-8.
15. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51:831-6.
16. Ida N, Sakurai S, Hosaka T, Hosoi K, Kunitomo T, Shimazu T, et al. Establishment of strongly neutralizing antibody to human IL-6 and its epitope analysis. Biochem Biophys Res Commun 1989;165:728-34.
17. Novick D, Engelmann H, Ravel M, Leitner O, Rubinstein M. Monoclonal antibodies to the soluble IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 1991;10:137-46.
18. Yasukawa K, Saito T, Fukunaga T, Sekimori Y, Koishihara Y, Fukui H, et al. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J Biochem 1990;108:673-6.
19. Bouchardy B, Majno G. Histopathology of early myocardial infarcts. Am J Pathol 1974;74:301-30.
20. Pasternak RC, Braunwald E, Sobel B. Acute myocardial infarction. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: WB Saunders; 1997. p. 1201-5.
21. Kushner I, Broder ML, Karp D. Control of the acute-phase response. Serum C-reactive protein kinetics after myocardial infarction. J Clin Invest 1978;61:235-42.
22. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-84.
23. Thivierge M, Rola-Pleszczynski M. Improvement of both cyclooxygenase and lipoxygenase pathways in platelet-activating factor-induced interleukin-6 production by alveolar macrophages. Ann N Y Acad Sci 1994;725:213-22.
24. Williams JA, Shacter E. Regulation of macrophage cytokine production by prostaglandin E2. J Biol Chem 1997;272:25693-9.
25. Nakamura A, Kohsaka T, Jin D, Kobayashi N. Influence of glucocorticoid, aspirin, and gamma globulin on interleukin-6 production in the hepatoma cell line. Immunopharmacology 1992;24;31-6.
26. Sobel BE, Roberts R, Larson KB. Considerations in the use of biochemical markers of ischemic injury. Circ Res 1976;38 Suppl 1:99-108.
27. Pannitteri G, Marino B, Campa PP, Martucci R, Testa U, Peschle C. Interleukin 6 and 8 as mediators of acute-phase response in acute myocardial infarction. Am J Cardiol 1997;80:622-5.
28. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127:263-71.
29. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
30. Szekanecz Z, Shar MR, Pearce WH, Koch AE. Human atherosclerotic abdominal aortic aneurysms produce interleukin(IL)-6 and interferongamma but not IL-2 and IL-4: the possible role for IL-6 and interferongamma in vascular inflammation. Agents Actions 1994;42:159-62.
31. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-7.
32. Frieling JTM, Van Deuren M, Wijdenes J, Meer JWM, Clement C, Linden C J, et al. Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis 1995;171:469-72.
33. Bencosme A, Warner A, Healy D, Verme C. Prognostic potential of cytokines, and Apache II score in sepsis. Ann Clin Lab Sci 1996; 26:426-32.
34. Benedetti FD, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin-6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
35. Girasole MSG, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, et al. Increased serum concentrations of interleukin-6 (II-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996;81:2976-9.
36. Ohtani K, Ninomiya H, Hasegawa Y, Kobayashi T, Kojima H, Nagasawa T, et al. Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias. Br J Haematol 1995;91:116-20.
37. Schroder W, Gaetje R, Baumann R. Interleukin-6 and soluble interleukin-6 receptor in patients with endometriosis. Clin Exp Obstet Gynecol 1996;23:10-4.
38. Gaillad JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, et al. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 1993;23:820-4.
39. Frieling J, Sauerwein R, Wijdenes J, Hendriks T, van der Linden C. Soluble interleukin-6 receptor in biological fluids from human origin. Cytokine 1994;6:376-81.
40. Müllburg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, et al. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993;23:437-80.
41. Horiuchi S, Koyanagi Y, Zhou Y, Miyamoto H, Tanaka Y. Interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 1994; 24:1945-8.
42. Zohlnhöfer D, Graeve L, Rose-John S, Schooltink H, Dittrich E, Heinrich PC. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (GP 80) by its ligand. FEBS Lett 1992; 306:219-22.
43. Snyers L, Content J. Enhancement of IL-6 receptor β chain (GP 130) expression by IL-6, IL-1 and TNF in human epithelial cells. Biochem Biophys Res Commun 1992;185:902-8.
44. Graeve L, Kololenko TA, Hemmann U, Weiergäber O, Dittrich E, Heinrich PC. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer GP l30. FEBS Lett 1996;399:131-4.